ArticleEuropean heart journal. Cardiovascular pharmacotherapy2023

Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.

Gerasimos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.